Cleared Traditional

K023269 - HEMOSIL C-REACTIVE PROTEIN - HIGH SENSITIVITY AND HIGH SENSITIVITY CONTROLS (FDA 510(k) Clearance)

Dec 2002
Decision
83d
Days
Class 2
Risk

K023269 is an FDA 510(k) clearance for the HEMOSIL C-REACTIVE PROTEIN - HIGH SENSITIVITY AND HIGH SENSITIVITY CONTROLS. This device is classified as a C-reactive Protein, Antigen, Antiserum, And Control (Class II - Special Controls, product code DCK).

Submitted by Instrumentation Laboratory CO (Bedford, US). The FDA issued a Cleared decision on December 23, 2002, 83 days after receiving the submission on October 1, 2002.

This device falls under the Chemistry FDA review panel. Regulated under 21 CFR 866.5270.

Submission Details

510(k) Number K023269 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received October 01, 2002
Decision Date December 23, 2002
Days to Decision 83 days
Submission Type Traditional
Review Panel Chemistry (CH)
Summary Summary PDF

Device Classification

Product Code DCK — C-reactive Protein, Antigen, Antiserum, And Control
Device Class Class II - Special Controls
CFR Regulation 21 CFR 866.5270